It can be very overwhelming scrolling though job board after job board in search of a position that fits your wants and needs. Let us take that stress away by finding a mix of…
Continue Reading
Biopharmaceutical company Pfizer is starting to serve consumers directly through its new telehealth platform called PfizerForAll, the company announced Tuesday. Pfizer declared that the platform is needed as consumers battle a confusing healthcare system.
PfizerForAll…
Continue Reading
This week more vendors announce integrations with artificial intelligence-driven tools and platforms that better connect patients and doctors during visits, find and lower specialty medication costs and access care resources at home or on…
Continue Reading
It can be very overwhelming scrolling though job board after job board in search of a position that fits your wants and needs. Let us take that stress away by finding a mix of…
Continue Reading
What You Should Know:
– Pharmaceutical giant Pfizer launches PfizerForAll, a user-friendly platform designed to simplify access to healthcare and wellness management for Americans.
– PfizerForAll addresses a common frustration: the difficulty of navigating the US…
Continue Reading
Israeli startup CytoReason, maker of a computation model to map and compare treatments, announced it secured $80 million in funding. Pfizer, OurCrowd, NVIDIA and Thermo Fisher Scientific participated in the round.
WHAT IT DOES
CytoReason offers life…
Biopharmaceutical leaders Pfizer mapped out an exciting journey in AI and gene therapy in the Middle East, Russia and Africa (MERA), as its regional headquarters in Dubai marked their 175th anniversary on Tuesday.
Patrick van…
Collaborating for biologic breakthroughs, IBM and Boehringer Ingelheim merge genAI with foundation models. IBM’s cutting-edge AI expedites antibody discovery, targeting diseases like cancer, autoimmune disorders, and infections. Boehringer’s validation of refined antibodies affirms in-silico…
Continue Reading
FDA has approved Pfizer’s Abrysvo, the first vaccine for gestational immunization, safeguarding infants up to 6 months from respiratory syncytial virus (RSV) ailments. Administered during weeks 32-36 of pregnancy, Abrysvo was proven effective in…
Continue Reading
Dave Hodgson is co-founder and CEO of Project Ronin of San Mateo, CA.
Tell me about yourself and the company.
I’m a molecular biologist by training. I started my first job on the genome project in…
